News & Updates
Filter by Specialty:
Show Multimedia Only

Two-drug combo rises to the challenge as 1L Tx for mTNBC
02 Jul 2025
byAudrey Abella
In the primary analysis of the ASCENT-04/KEYNOTE-D19 study, a combination regimen comprising sacituzumab govitecan (SG) and pembrolizumab delivers significant progression-free survival (PFS) benefit in women with previously untreated PD-L1+ advanced triple-negative breast cancer (TNBC).
Two-drug combo rises to the challenge as 1L Tx for mTNBC
02 Jul 2025
DASH diet during pregnancy helps prevent LGA newborns
11 Jun 2025
byStephen Padilla
Pregnant women with high adherence to the Dietary Approaches to Stop Hypertension (DASH) diet have a much lower chance of having large-for-gestational-age (LGA) newborns, reports a Brazil study.